Adicet Bio Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies ...
The characterization of product-related variants in monoclonal antibodies involves identifying and quantifying the size and charge of variants that can impact.. In biotherapeutics manufacturing, ...
Charles Sternberg is a driven writer and editor with a well developed passion for creativity and innovation seeking to ...
The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across ...
Evidence of efficacy and safety data support the potential for vatiquinone to fill the significant unmet need for patients ...
Will support clinical development of Nirsum’s lead development candidate, NRS-033.
Prasinezumab continues to be well tolerated and no new safety signals were observed.
A Phase 2 study showed encouraging results with Trodelvy as a second-line treatment for extensive-stage small cell lung ...
Great Bay Bio (GBB) announced today the first close of its Series B financing round, led by a strategic investment ...
With a total area exceeding 16,000 square meters, the new facility houses the company's production, quality, data, and ...
Demonstrates its commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve.
Biomedicines as part of its efforts to drive growth and innovation in the biopharmaceutical sector. Established in 2021 and ...